Category Archives: INNOVATION

4 Possible Biotech Takeover Targets for 2018

4 Possible Biotech Takeover Targets for 2018

Acquisitions of small-cap drug/biotech companies are very difficult to predict and quite frequent. …read more Source:: 4 Possible Biotech Takeover Targets for 2018       Continue Reading

71% of ALL Patients Achieved Complete Tumor Remission on Gilead, Kite’s CAR-T Therapy

71% of ALL Patients Achieved Complete Tumor Remission on Gilead, Kite’s CAR-T Therapy

The ZUMA-3 study results were presented in an oral session at the Annual Meeting of the ASH in Atlanta. …read more Source:: 71% of ALL Patients Achieved Complete Tumor Remission on Gilead, Kite’s CAR-T Therapy       Continue Reading

Allergan Swoops in and Bags Troubled Repros Therapeutics

Allergan Swoops in and Bags Troubled Repros Therapeutics

The Company’s Board of Directors has unanimously approved the transaction. …read more Source:: Allergan Swoops in and Bags Troubled Repros Therapeutics       Continue Reading

Bay Area’s Aduro Biotech Throws in Towel on CRS-207, Will Wind Down Trials

Bay Area’s Aduro Biotech Throws in Towel on CRS-207, Will Wind Down Trials

Aduro will be working closely with investigators to proceed in a manner that is aligned with the best interests of patients still being treated on these studies. …read more Source:: Bay Area’s Aduro Biotech Throws in Towel on CRS-207, Will Wind Down Trials       Continue Reading

FDA Approves Sanofi’s Admelog, the First Follow-On Insulin to Control Sugar at Mealtime

FDA Approves Sanofi’s Admelog, the First Follow-On Insulin to Control Sugar at Mealtime

Admelog is a rapid-acting insulin similar to Humalog, another insulin lispro 100 Units/mL, currently approved in the U.S. …read more Source:: FDA Approves Sanofi’s Admelog, the First Follow-On Insulin to Control Sugar at Mealtime       Continue Reading

Community  | Groups  | Members  | Register  | Blog  | Contact  | Terms of Engagement